相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Prediction of Insulin Resistance and Impaired Fasting Glucose Based on Sex Hormone-Binding Globulin (SHBG) Levels in Polycystic Ovary Syndrome
Aleksandra Biernacka-Bartnik et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2022)
Liraglutide monotherapy and add on therapy on obese women with polycystic ovarian syndromes: a systematic review and meta-analysis
Dan Tian et al.
MINERVA MEDICA (2022)
Clinical Presentation and Diagnosis of Polycystic Ovarian Syndrome
Jessica A. Lentscher et al.
CLINICAL OBSTETRICS AND GYNECOLOGY (2021)
Pathophysiological roles of chronic low-grade inflammation mediators in polycystic ovary syndrome
Maryam Rostamtabar et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2021)
Associations of insulin resistance, sex hormone-binding globulin, triglyceride, and hormonal profiles in polycystic ovary syndrome: A cross-sectional study
Bahia Namavar Jahromi et al.
INTERNATIONAL JOURNAL OF REPRODUCTIVE BIOMEDICINE (2021)
Mechanisms of Insulin Resistance at the Crossroad of Obesity with Associated Metabolic Abnormalities and Cognitive Dysfunction
Thomas M. Barber et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)
Long-term androgen excess induces insulin resistance and non-alcoholic fatty liver disease in PCOS-like rats
Peng Cui et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2021)
Eight-hour time-restricted feeding improves endocrine and metabolic profiles in women with anovulatory polycystic ovary syndrome
Chunzhu Li et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2021)
Impact of bariatric surgery on androgen profile and ovarian volume in obese polycystic ovary syndrome patients with infertility
Rania S. Ezzat et al.
SAUDI JOURNAL OF BIOLOGICAL SCIENCES (2021)
The prevalence of anxiety and depression of different severity in women with polycystic ovary syndrome: a meta-analysis
Yulu Wang et al.
GYNECOLOGICAL ENDOCRINOLOGY (2021)
Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study
Thomas R. Berni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
DHT causes liver steatosis via transcriptional regulation of SCAP in normal weight female mice
Tina Seidu et al.
JOURNAL OF ENDOCRINOLOGY (2021)
Current management of NAFLD/NASH
Ana Carolina Cardoso et al.
LIVER INTERNATIONAL (2021)
Non-alcoholic fatty liver disease in premenopausal women with polycystic ovary syndrome: A systematic review and meta-analysis
Mohamed Shengir et al.
JGH OPEN (2021)
Women With Polycystic Ovary Syndrome Have an Increased Risk of Major Cardiovascular Events: a Population Study
Thomas R. Berni et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2021)
Polycystic ovarian syndrome: Correlation between hyperandrogenism, insulin resistance and obesity
Xin Zeng et al.
CLINICA CHIMICA ACTA (2020)
Polycystic ovary syndrome (PCOS) is associated with NASH severity and advanced fibrosis
Monika Sarkar et al.
LIVER INTERNATIONAL (2020)
Polycystic ovary syndrome with feasible equivalence to overweight as a risk factor for non-alcoholic fatty liver disease development and severity in Mexican population
Nicolas Salva-Pastor et al.
ANNALS OF HEPATOLOGY (2020)
The polycystic ovary syndrome and gynecological cancer risk
Blazej Meczekalski et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Effect of DHT-Induced Hyperandrogenism on the Pro-Inflammatory Cytokines in a Rat Model of Polycystic Ovary Morphology
Abhaya Krishnan et al.
Medicina-Lithuania (2020)
Spironolactone reversed hepato-ovarian triglyceride accumulation caused by letrozole-induced polycystic ovarian syndrome: tissue uric acid-a familiar foe
Oluwaseun A. Adeyanju et al.
NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY (2020)
Evolution of NAFLD and Its Management
Manpreet S. Mundi et al.
NUTRITION IN CLINICAL PRACTICE (2020)
Inflammatory Markers in Women with Polycystic Ovary Syndrome
E. Rudnicka et al.
BIOMED RESEARCH INTERNATIONAL (2020)
Effect of lifestyle modifications on anthropometric, clinical, and biochemical parameters in adolescent girls with polycystic ovary syndrome: a systematic review and meta-analysis
Somayeh Abdolahian et al.
BMC ENDOCRINE DISORDERS (2020)
The Role of Insulin Resistance and Diabetes in Nonalcoholic Fatty Liver Disease
Hideki Fujii et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2020)
From Prediabetes to Type 2 Diabetes Mellitus in Women with Polycystic Ovary Syndrome: Lifestyle and Pharmacological Management
Arianna Pani et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
The Effect of Metformin on Polycystic Ovary Syndrome in Overweight Women: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
Yuanyuan Guan et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2020)
Prevalence and predictors of nonalcoholic fatty liver disease in South Asian women with polycystic ovary syndrome
Mohamed Shengir et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2020)
Involvement of endogenous testosterone in hepatic steatosis in women with polycystic ovarian syndrome
Tianhe Li et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2020)
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome: associated factors and noninvasive fibrosis staging in a single Brazilian center
Daniela Oliveira de Lima Taranto et al.
ARCHIVES OF ENDOCRINOLOGY METABOLISM (2020)
Fibroscan as a non-invasive predictor of hepatic steatosis in women with polycystic ovary syndrome
Semanti Chakraborty et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2020)
Effects of bariatric surgery on obese polycystic ovary syndrome: a systematic review and meta-analysis
Ying-Jie Li et al.
SURGERY FOR OBESITY AND RELATED DISEASES (2019)
Role of vitamin E in nonalcoholic fatty liver disease
Mayumi Nagashimada et al.
IUBMB LIFE (2019)
Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2019)
A Randomized, Controlled Trial of Vitamin D Supplementation on Cardiovascular Risk Factors, Hormones, and Liver Markers in Women with Polycystic Ovary Syndrome
Zeeshan Javed et al.
NUTRIENTS (2019)
Obesity and Polycystic Ovary Syndrome: Implications for Pathogenesis and Novel Management Strategies
Thomas M. Barber et al.
CLINICAL MEDICINE INSIGHTS-REPRODUCTIVE HEALTH (2019)
Insulin resistance and hyperandrogenemia independently predict nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Sree Harsha Varma et al.
DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS (2019)
Epidemiology, pathogenesis, genetics & management of polycystic ovary syndrome in India
Mohammad Ashraf Ganie et al.
INDIAN JOURNAL OF MEDICAL RESEARCH (2019)
Lifestyle changes in women with polycystic ovary syndrome
Siew S. Lim et al.
COCHRANE DATABASE OF SYSTEMATIC REVIEWS (2019)
Global burden of NAFLD and NASH: trends, predictions, risk factors and prevention
Zobair Younossi et al.
NATURE REVIEWS GASTROENTEROLOGY & HEPATOLOGY (2018)
Metabolic Regulation of Adipose Tissue Macrophage Function in Obesity and Diabetes
Mahesh Appari et al.
ANTIOXIDANTS & REDOX SIGNALING (2018)
Inter-related effects of insulin resistance, hyperandrogenism, sympathetic dysfunction and chronic inflammation in PCOS
Soulmaz Shorakae et al.
CLINICAL ENDOCRINOLOGY (2018)
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Hector F. Escobar-Morreale
NATURE REVIEWS ENDOCRINOLOGY (2018)
Bariatric Surgery Improves Hyperandrogenism, Menstrual Irregularities, and Metabolic Dysfunction Among Women with Polycystic Ovary Syndrome (PCOS)
Jacob P. Christ et al.
OBESITY SURGERY (2018)
Analyses of risk factors for polycystic ovary syndrome complicated with non-alcoholic fatty liver disease
Jianhai Zhang et al.
EXPERIMENTAL AND THERAPEUTIC MEDICINE (2018)
Dehydroepiandrosterone-induced activation of mTORC1 and inhibition of autophagy contribute to skeletal muscle insulin resistance in a mouse model of polycystic ovary syndrome
Xi Song et al.
Oncotarget (2018)
Long-Lasting Androgen-Induced Cardiometabolic Effects in Polycystic Ovary Syndrome
Edgar D. Torres Fernandez et al.
JOURNAL OF THE ENDOCRINE SOCIETY (2018)
Effect of liraglutide on ectopic fat in polycystic ovary syndrome: A randomized clinical trial
Signe Frossing et al.
DIABETES OBESITY & METABOLISM (2018)
The Effects of Omega-3 Fatty Acids and Vitamin E -Co-Supplementation on Indices of Insulin Resistance and Hormonal Parameters in Patients with Polycystic Ovary Syndrome: A Randomized, Double-Blind, Placebo-Controlled Trial
Faraneh Afshar Ebrahimi et al.
EXPERIMENTAL AND CLINICAL ENDOCRINOLOGY & DIABETES (2017)
High-free androgen index is associated with increased risk of non-alcoholic fatty liver disease in women with polycystic ovary syndrome, independent of obesity and insulin resistance
J. Cai et al.
INTERNATIONAL JOURNAL OF OBESITY (2017)
The effects of omega-3 fatty acids and vitamin E co-supplementation on gene expression of lipoprotein(a) and oxidized low-density lipoprotein, lipid profiles and biomarkers of oxidative stress in patients with polycystic ovary syndrome
Elham Rahmani et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2017)
Insulin resistance and hyperandrogenism drive steatosis and fibrosis risk in young females with PCOS
Salvatore Petta et al.
PLOS ONE (2017)
Effects of liraglutide on ovarian dysfunction in polycystic ovary syndrome: a randomized clinical trial
Malin Nylander et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2017)
Clinical epidemiology and disease burden of nonalcoholic fatty liver disease
Brandon J. Perumpail et al.
WORLD JOURNAL OF GASTROENTEROLOGY (2017)
Impaired branched-chain amino acid metabolism may underlie the nonalcoholic fatty liver disease-like pathology of neonatal testosterone-treated female rats
Alvaro Anzai et al.
SCIENTIFIC REPORTS (2017)
Nonalcoholic Fatty Liver Disease in a Sample of Iranian Women with Polycystic Ovary Syndrome
Ferdous Mehrabian et al.
INTERNATIONAL JOURNAL OF PREVENTIVE MEDICINE (2017)
Comparison of the effect between pioglitazone and metformin in treating patients with PCOS:a meta-analysis
Yifeng Xu et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2017)
A dipose tissue, obesity and non-alcoholic fatty liver disease
Stergios A. Polyzos et al.
MINERVA ENDOCRINOLOGICA (2017)
Comparison of spironolactone and spironolactone plus metformin in the treatment of polycystic ovary syndrome
Halit Diri et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Treatment of nonalcoholic fatty liver disease: role of AMPK
Brennan K. Smith et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2016)
Long-Term Pioglitazone Treatment for Patients With Nonalcoholic Steatohepatitis and Prediabetes or Type 2 Diabetes Mellitus A Randomized Trial
Kenneth Cusi et al.
ANNALS OF INTERNAL MEDICINE (2016)
Criteria, prevalence, and phenotypes of polycystic ovary syndrome
Daria Lizneva et al.
FERTILITY AND STERILITY (2016)
Global Epidemiology of Nonalcoholic Fatty Liver Disease-Meta-Analytic Assessment of Prevalence, Incidence, and Outcomes
Zobair M. Younossi et al.
HEPATOLOGY (2016)
Non-alcoholic fatty liver disease is associated with insulin resistance and lipid accumulation product in women with polycystic ovary syndrome
D. Macut et al.
HUMAN REPRODUCTION (2016)
Adipokines in in nonalcoholic fatty liver disease
Stergios A. Polyzos et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
The multiple-hit pathogenesis of non-alcoholic fatty liver disease (NAFLD)
Elena Buzzetti et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2016)
Sex hormone-binding globulin regulation of androgen bioactivity in vivo: validation of the free hormone hypothesis
Michael R. Laurent et al.
SCIENTIFIC REPORTS (2016)
Weight Loss Through Lifestyle Modification Significantly Reduces Features of Nonalcoholic Steatohepatitis
Eduardo Vilar-Gomez et al.
GASTROENTEROLOGY (2015)
Peripheral and Hepatic Vein Cytokine Levels in Correlation with Non-Alcoholic Fatty Liver Disease (NAFLD)-Related Metabolic, Histological, and Haemodynamic Features
Luisa Vonghia et al.
PLOS ONE (2015)
Adipose tissue dysfunction, adipokines, and low-grade chronic inflammation in polycystic ovary syndrome
Poli Mara Spritzer et al.
REPRODUCTION (2015)
Non-alcoholic fatty liver disease in women with polycystic ovary syndrome - clinical and metabolic aspects and lipoprotein lipase gene polymorphism
Anna Bohdanowicz-Pawlak et al.
ENDOKRYNOLOGIA POLSKA (2014)
Glucagon-like peptide-1 analogue, liraglutide, improves liver fibrosis markers in obese women with polycystic ovary syndrome and nonalcoholic fatty liver disease
H. Kahal et al.
CLINICAL ENDOCRINOLOGY (2014)
Evolving Concepts in the Pathogenesis of NASH: Beyond Steatosis and Inflammation
William Peverill et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2014)
Understanding androgen action in adipose tissue
Michael W. O'Reilly et al.
JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY (2014)
The brown fat-enriched secreted factor Nrg4 preserves metabolic homeostasis through attenuation of hepatic lipogenesis
Guo-Xiao Wang et al.
NATURE MEDICINE (2014)
In PCOS patients the addition of low-dose spironolactone induces a more marked reduction of clinical and biochemical hyperandrogenism than metformin alone
A. Mazza et al.
NUTRITION METABOLISM AND CARDIOVASCULAR DISEASES (2014)
Genetics of Polycystic Ovary Syndrome
Corrine K. Welt et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2014)
Cannabinoid Receptor 1 Gene Polymorphisms and Nonalcoholic Fatty Liver Disease in Women with Polycystic Ovary Syndrome and in Healthy Controls
Justyna Kuliczkowska Plaksej et al.
INTERNATIONAL JOURNAL OF ENDOCRINOLOGY (2014)
Epidemiology, diagnosis, and management of polycystic ovary syndrome
Susan M. Sirmans et al.
CLINICAL EPIDEMIOLOGY (2014)
The effect of liraglutide on weight loss in women with polycystic ovary syndrome: an observational study
Christina B. Rasmussen et al.
FRONTIERS IN ENDOCRINOLOGY (2014)
Pharmacology, Physiology, and Mechanisms of Incretin Hormone Action
Jonathan E. Campbell et al.
CELL METABOLISM (2013)
Serum free fatty acid levels in PCOS patients treated with glucophage, magnesium oxide and spironolactone
Ozgul Muneyyirci-Delale et al.
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Circulating Sfrp5 Is a Signature of Obesity-Related Metabolic Disorders and Is Regulated by Glucose and Liraglutide in Humans
Wenjing Hu et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Mechanisms of hepatic triglyceride accumulation in non-alcoholic fatty liver disease
Yuki Kawano et al.
JOURNAL OF GASTROENTEROLOGY (2013)
Molecular signature of adipose tissue in patients with both Non-Alcoholic Fatty Liver Disease (NAFLD) and Polycystic Ovarian Syndrome (PCOS)
Ancha Baranova et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2013)
Cardiometabolic health among gastric bypass surgery patients with polycystic ovarian syndrome
Carley A. Gomez-Meade et al.
WORLD JOURNAL OF DIABETES (2013)
Cellular and molecular mechanisms of metformin: an overview
Benoit Viollet et al.
CLINICAL SCIENCE (2012)
Evaluation of body fat distribution in PCOS and its association with carotid atherosclerosis and insulin resistance
Aysun Karabulut et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Polycystic Ovary Syndrome with Hyperandrogenism Is Characterized by an Increased Risk of Hepatic Steatosis Compared to Nonhyperandrogenic PCOS Phenotypes and Healthy Controls, Independent of Obesity and Insulin Resistance
Helen Jones et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2012)
Obesity and PCOS: Implications for Diagnosis and Treatment
Richard S. Legro
SEMINARS IN REPRODUCTIVE MEDICINE (2012)
Ultrasonographic and laboratory markers of metabolic and cardiovascular disease risk in obese women with polycystic ovary syndrome
L. F. N. Zueff et al.
ULTRASOUND IN OBSTETRICS & GYNECOLOGY (2012)
Long-term metformin treatment is able to reduce the prevalence of metabolic syndrome and its hepatic involvement in young hyperinsulinaemic overweight patients with polycystic ovarian syndrome
Maria F. Gangale et al.
CLINICAL ENDOCRINOLOGY (2011)
Current perspectives of insulin resistance and polycystic ovary syndrome
J. M. Pauli et al.
DIABETIC MEDICINE (2011)
The role of thiazolidinediones in non-alcoholic steatohepatitis - A systematic review and meta analysis
Suzanne E. Mahady et al.
JOURNAL OF HEPATOLOGY (2011)
Non-alcoholic steatohepatitis (NASH) in patients with polycystic ovarian syndrome (PCOS)
Noreen Hossain et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2011)
Treatment options for polycystic ovary syndrome
Ahmed Badawy et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2011)
Increased androgen bioavailability is associated with non-alcoholic fatty liver disease in women with polycystic ovary syndrome
E. Vassilatou et al.
HUMAN REPRODUCTION (2010)
Apoptotic Markers Indicate Nonalcoholic Steatohepatitis in Polycystic Ovary Syndrome
Susanne Tan et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2010)
Omega-3 Fatty Acid Supplementation Decreases Liver Fat Content in Polycystic Ovary Syndrome: A Randomized Controlled Trial Employing Proton Magnetic Resonance Spectroscopy
Andrea J. Cussons et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2009)
AMPK in Health and Disease
Gregory R. Steinberg et al.
PHYSIOLOGICAL REVIEWS (2009)
Incretin levels in polycystic ovary syndrome
Jana Vrbikova et al.
EUROPEAN JOURNAL OF ENDOCRINOLOGY (2008)
Randomized, placebo-controlled trial of pioglitazone in nondiabetic subjects with nonalcoholic steatohepatitis
Guruprasad P. Aithal et al.
GASTROENTEROLOGY (2008)
The effects of 8 months of metformin on circulating GGT and ALT levels in obese women with polycystic ovarian syndrome
D. Preiss et al.
INTERNATIONAL JOURNAL OF CLINICAL PRACTICE (2008)
Pioglitazone and risk of cardiovascular events in patients with type 2 diabetes mellitus - A meta-analysis of randomized trials
A. Michael Lincoff et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2007)
Nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Cristian Cerda et al.
JOURNAL OF HEPATOLOGY (2007)
Prevalence of nonalcoholic fatty liver disease in women with polycystic ovary syndrome
Maya Gambarin-Gelwan et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2007)
Peroxisome proliferator-activated receptors as transcriptional nodal points and therapeutic targets
Jonathan D. Brown et al.
CIRCULATION (2007)
Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline
Ricardo Azziz et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Nonalcoholic steatohepatitis and nonalcoholic fatty liver disease in young women with polycystic ovary syndrome
TL Setji et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2006)
Insulin resistance in the skeletal muscle of women with PCOS involves intrinsic and acquired defects in insulin signaling
A Corbould et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2005)
Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome
J Chang et al.
FERTILITY AND STERILITY (2004)
Role of AMP-activated protein kinase in mechanism of metformin action
GC Zhou et al.
JOURNAL OF CLINICAL INVESTIGATION (2001)
分享论文
